Literature DB >> 20826901

CT reconstruction from portal images acquired during volumetric-modulated arc therapy.

G Poludniowski1, M D R Thomas, P M Evans, S Webb.   

Abstract

Volumetric-modulated arc therapy (VMAT), a form of intensity-modulated arc therapy (IMAT), has become a topic of research and clinical activity in recent years. As a form of arc therapy, portal images acquired during the treatment fraction form a (partial) Radon transform of the patient. We show that these portal images, when used in a modified global cone-beam filtered backprojection (FBP) algorithm, allow a surprisingly recognizable CT-volume to be reconstructed. The possibility of distinguishing anatomy in such VMAT-CT reconstructions suggests that this could prove to be a valuable treatment position-verification tool. Further, some potential for local-tomography techniques to improve image quality is shown.

Entities:  

Mesh:

Year:  2010        PMID: 20826901     DOI: 10.1088/0031-9155/55/19/002

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  4 in total

1.  Feasibility of 3D tracking and adaptation of VMAT based on VMAT-CT.

Authors:  Xiaodong Zhao; Rui Zhang
Journal:  Radiother Oncol       Date:  2020-04-24       Impact factor: 6.280

2.  Reconstruction of the treatment area by use of sinogram in helical tomotherapy.

Authors:  Akihiro Haga; Keiichi Nakagawa; Calvin Maurer; Ken Ruchala; Edward Chao; Dylan Casey; Satoshi Kida; Dousatsu Sakata; Masahiro Nakano; Taiki Magome; Yoshitaka Masutani
Journal:  Radiat Oncol       Date:  2014-11-28       Impact factor: 3.481

3.  Quality control of VMAT synchronization using portal imaging.

Authors:  James L Bedford; Honorata Chajecka-Szczygielska; Michael D R Thomas
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

4.  Optimisation of a composite difference metric for prompt error detection in real-time portal dosimetry of simulated volumetric modulated arc therapy.

Authors:  James L Bedford; Ian M Hanson
Journal:  Br J Radiol       Date:  2021-03-18       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.